🟢 Gyre Therapeutics is trading 5% up today as biotech ETF XBI gains

Gyre Therapeutics is trading 5.01% up now at $7.54, primarily driven by biotech-sector strength.

• The move extends the September 17, 2026 close of $7.18, which gained 7.16%.
• Biotech ETF XBI is up 2.55% during regular trading, supported by a stronger industry outlook, improving funding conditions, and M&A optimism.
• No clear September 18 company-specific announcement was identified; Morgan Stanley conference coverage discussed the pipeline but did not explicitly link it to the share-price rise.